Register Now
Read Article
The role of basivertebral nerve ablation (BVNA) in vertebrogenic low back pain is evolving, but gaps remain in understanding who benefits most—and at what cost. This narrative review synthesizes current evidence on patient selection criteria, clinical outcomes, and the healthcare utilization and economic implications of BVNA. Key topics include predictors of treatment response, long-term pain and functional results, comparative cost analyses, and strategies to balance benefit with resource stewardship. For spine surgeons, pain specialists, and other practitioners committed to evidence-driven care, this article offers a comprehensive framework to guide optimal patient referral, shared decision-making, and value-based deployment of BVNA in practice.
Up to 0.5 CME available.
Learn More